Online Order Get In Touch
CN JP KR

What would you like to find?

About PackGene

PackGene Biotech was founded in 2014 by visionary scientists dedicated to making life-changing gene therapies universally accessible. Recognizing the immense promise and critical challenges of AAV vector production, we set out to revolutionize AAV manufacturing and broader gene therapy production through innovation, scalability, and cost-efficiency.

 

As a world-leading CRO and CDMO, we excel in providing comprehensive AAV vector, mRNA, plasmid DNA, and lentiviral vector solutions. Our offerings support early-stage drug discovery, preclinical development, and clinical trials with reliable, cost-effective, and scalable production. We've developed the groundbreaking π-Alpha 293 AAV High-yield Platform, which amplifies AAV production up to 10-fold, reaching 1E+17vg per batch. We also provide seamless, end-to-end plasmid, mRNA and LNP products and services from research to GMP.

 

Our work truly touches lives. We've had the honor of witnessing gene therapy deliver profound change: seeing children with Rett Syndrome (RTT) regain strength, families battling ALS (Amyotrophic Lateral Sclerosis) find renewed hope, and individuals with X-linked retinoschisis envision a clearer tomorrow. One of our most moving moments involved a young boy born with congenital deafness who, after receiving an AAV therapy using material manufactured by PackGene, heard his family’s voices for the first time and spoke his first word. These deeply personal stories inspire our unwavering belief: gene therapy should be accessible, because every life transformed is a future reclaimed. Learn more….

 

Today, PackGene stands as a global leader, partnering with over 1,000 biopharmaceutical companies and research institutions in more than 30 countries. Our slogan, "Make Gene Therapy Affordable," encapsulates our mission. We are dedicated to tackling key challenges in gene therapy development, including viral vector production, novel capsid engineering, mRNA manufacturing, analytical tests, and plasmid production from early research and development to GMP manufacturing for clinical trials. By providing stable, high-quality, cost-efficient, and rapid services, coupled with expert technical support, we empower our gene therapy partners to transform lives and build a healthier, better world together.

Expand More
  • 1,000+

    Clients globally

    From biopharmaceutical companies and research institutions
  • 50,000+

    Projects delivered

    From research to GMP production
  • 120,000sqf

    GMP facility

    Viral Vector production

Missions and Values

  • Introduction

    PackGene aims to Make Gene Therapy Affordable. We focus our work on several challenge areas within for rAAV based therapeutic pipeline including rAAV serotype selection, viral vector packaging, and GMP production at scale. We aim to provide stable, qualified, and cost-efficient fast services and technical support within these challenging areas with the overarching goal of helping our gene therapy partners make a better world.

  • Mission Statement

    Make Gene Therapy Affordable: To enhance gene therapy product development by providing an integrated one-stop shop solution to the gene therapy industry with high-quality products and services under world-class speed.

  • Vision Statement

    Gene therapies are poised to revolutionize the world of medicine and address areas of unmet medical needs. PackGene’s proprietary π-Alpha 293 AAV High-yield Platform is positioned to alleviate industry-wide productivity bottlenecks while maintaining product safety.

    PackGene strives to deliver the most efficient gene therapy manufacturing platform, making novel gene therapies accessible and more affordable to patients in need.

  • Core Values

    • Integrity: We do what we say and say what we do.
    • Innovation: Continuously improve our process to bring better therapies to the patients.
    • Patient First: We always put patients first in our day-to-day operations.
    • Customer dedication: We strive to exceed customers’ expectations in everyday work.
    • World-class delivery speed: It’s part of our genome to always provide world-class turnaround times because patients are waiting.
  • Introduction
  • Mission Statement
  • Vision Statement
  • Core Values

Investor Relations

PackGene stands at the forefront as a global leader CRO and CDMO

Established in Massachusetts, USA, PackGene is currently expanding its capabilities with the construction of a GMP facility in Houston, Texas. The company provides a comprehensive range of services, including the production of rAAV-based GMP grade gene therapeutics, rAAV packaging, lentivirus packaging, mRNA, LNP, plasmid, and vector cloning. These initiatives have garnered widespread international collaboration and financial backing.

Contact Us

Distributor Recruitment

Contact Us

Download

Login

Don't have an account? Please register
Account*
Password*
Code*
Refresh
Forgot password?
Logging in indicates that you have read and accepted the Registration Agreement and User Agreement
Log in with other accounts

New User Registration

Already have an account?
First Name*
Middle Name
Last Name*
Organization*
Organization Type*
Country/State*
Email Address*
Set Password*
Confirm password*
Refferal Code*

Reset Password

Return to
Email*
Code*
New password*
Confirm password*

Google Account Binding

Organization*
Organization Type*
Country/State*